Blog Layout

The World's First Sterile CBD IV Solution Launched by Apex Labs CBD Pico IV
CAL • Jul 27, 2023

Pico IV is available to IV Therapy Centers across the US as a new way for customers to enjoy the benefits of CBD.

SACRAMENTO, Calif., July 25, 2023 /PRNewswire-PRWeb/ -- Apex Labs CBD has developed a groundbreaking new product that combines the world CBD with intravenous (IV) therapy. By pioneering a new form of technology, the team at Apex Labs CBD was able to reduce the size of the CBD molecule to make it both water-soluble and small enough to pass through a sterile filter, making it safe for intravenous use. This first-of-its-kind sterile CBD solution can bring the many benefits of cannabidiol and the hemp world to IV Therapy Clinics across the country and complement a variety of functional or regenerative medicine offerings.


The intravenous (IV) hydration therapy market has experienced tremendous growth in the last decade and is projected to continue growing over the coming years. It offers a safe and easy way to deliver nutrients and hydration directly into the bloodstream. Some of the most popular IV therapy treatments target everything from skincare and hydration to hangover remedies and overall health and wellness. Pico IV offers the opportunity to supplement these treatments with the unique benefits of CBD, allowing IV Therapy to create custom protocols for their customers.


CBD, or cannabidiol, is one of the many non-psychoactive components naturally derived from the hemp plant. It interacts naturally with the body to support overall health and well-being. It can also help reduce occasional feelings of stress or anxiety, support a healthy sleep cycle, and potentially ease aches or pains due to overexertion.* Pico IV uses the CBD isolate with zero THC from industrial-grown hemp in the USA. Thanks to its legalization in 2018 with the Farm Bill, the CBD industry has been experiencing tremendous growth.


"We were incredibly excited to be able to bring this product to the market," said Joe Young, CEO and co-founder of Apex Labs CBD. "Not only is it the merging of two really significant markets in the wellness industry, but it also represents how much potential there is when combining the power of science with one of nature's greatest gifts. We're proud to offer a new way for people to experience CBD."

The desire for a CBD intravenous solution has been present for years, as other methods of CBD usage, like ingestion, topical or sublingual, don't offer the same levels of system absorption as an IV solution. However, because the CBD molecule was too large to pass through a sterile filtration process, it would result in a non-sterile product. While recent developments in technology led to water-soluble CBD, and more recently, nanoemulsions, Miles Terry, (CSO, co-founder) created patent-pending technology that reduced the molecule size even further down to the size of a picometer, allowing for a sterile filtration process and maximum system absorptions.


Apex Labs CBD values quality and testing throughout the product development process. All products are sent to a third-party testing facility, California-Ag Labs, to test for potency and purity. The comprehensive test reports are published on the website and include test results for microbes, pesticides, metals, potency, mycotoxins, and residual solvents.


Robert Myer, owner of California Ag Labs, stated, "I am so thrilled for this development in the hemp world. I'm a long-time believer in the power of CBD and how it helps the body, naturally. To see this product realized is a dream come true. I believe it will open new doors for people to experience the benefits of CBD for themselves. And that's what we want, to make the best quality CBD more accessible to everyone."


Pico IV is currently available for purchase online after member registration. Each sterile vial has 50ml infused with approximately 200mg of CBD, or cannabidiol, and provides 4 doses at 50mg per dose. You must be a licensed IV therapy provider to purchase. For more information, visit PicoIV.com.


ABOUT APEX LABS CBD:

Founded in 2019, Apex Labs CBD began its mission to create top-quality CBD products on the market that are accessible to all. With a focus on product development, as well as rigorous testing and standards, the product offering grew to include everything from new cannabinoids to innovative product categories, like water-soluble tinctures and beverage enhancers. Apex Labs CBD offers both retail and B2B options, as well as a variety of resource services. With its expansion into the IV Therapy market, Apex Labs CBD will continue to operate with transparency, upholding high standards, all while creating new ways for people to experience the many benefits of CBD.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.


Media Contact

Anna Osborn, Apex Labs CBD/Pico IV, 855-900-0020, support@picoiv.com

 

SOURCE Apex Labs CBD/Pico IV

#picoiv


Share this Article

Latest on Intravenous Cannabidiol (CBD) in Cancer
By CAL 16 Apr, 2024
Intravenous administration of CBD and its relevant potential to improve health and decrease inflammation. Dr. Nathan Goodyear, M.D., a renowned Oncology specialist, shares his insights as a part of his journey utilizing CBD to support patient care.
Ensuring Safety in the Cannabis Industry: DCC Requires New Potency Testing SOP
By Stephanie Kerns 24 Jan, 2024
Redwood Community Radio KMUD Podcast: Understanding New Process for Laboratories in Compliance with the DCC Standard Cannabinoid Test Method
Share by: